⚖ Head-to-Head · GLP-1 vs Triple Agonist

Semaglutide vs Retatrutide

Mechanism, half-life, dosing & research status compared side-by-side.

Semaglutide
Metabolic / GLP-1 Agonist
Approved (T2D, obesity)
GLP-1 AgonistFDA ApprovedWeight ManagementMetabolicDiabetes
Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk. Approved for type 2 diabetes management and chronic weight management, it has become one of the most widely prescri…
Full Semaglutide profile →
Retatrutide
Metabolic / Triple Incretin Agonist
Phase 3 (obesity, T2D); not yet approved
GLP-1 AgonistGIP AgonistGlucagon AgonistWeight ManagementMetabolicPhase 3
Retatrutide is a first-in-class triple receptor agonist developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. By adding glucagon receptor activity to the dual incretin mechanism of tirz…
Full Retatrutide profile →
Technical Specs Comparison
MetricSemaglutideRetatrutide
Research Status FDA Approved Phase 3 Clinical Trials
Molecular Weight 4113.58 Da ~4.4 kDa
Half-Life ~168 hours (7 days) ~6 days
Peak Time 1-3 days post-injection 48-96 hours post-injection
Typical Dose 0.25-2.4 mg/week (SC); 3-14 mg/day (oral) 1-24 mg/week (Phase 2); Phase 3 doses TBD
Frequency Once weekly (SC); once daily (oral) Once weekly
Route Subcutaneous injection; oral tablet Subcutaneous injection
Amino Acids 31 36
WADA Status Not listed Not listed
FDA Status Approved (T2D, obesity) Phase 3 (obesity, T2D); not yet approved
Stack Compatibility & Key Differences
Semaglutide has FDA approval; Retatrutide is research-only.
PK Plotter · Visualize plasma levels over time
Plot Semaglutide → Plot Retatrutide →
Frequently Asked Questions
What is the difference between Semaglutide and Retatrutide?
Semaglutide: Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk. Approved for type 2 diabetes management and chronic weight management, it has become one of the most widely prescri… Retatrutide: Retatrutide is a first-in-class triple receptor agonist developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. By adding glucagon receptor activity to the dual incretin mechanism of tirz…
Can you stack Semaglutide and Retatrutide?
Semaglutide has FDA approval; Retatrutide is research-only.
Which has a longer half-life, Semaglutide or Retatrutide?
Semaglutide half-life: ~168 hours (7 days). Retatrutide half-life: ~6 days.
✓
Verified Scientific Data
All specifications on this page are sourced from peer-reviewed literature and primary research. Half-life values, dosing ranges, and mechanism data are cross-referenced against published studies. Last audited 2026-06-15.
● Peer-reviewed sources ● Audit timestamp: 2026-06-15 ● Data version: ASCEND Wiki 2026
Data sourced from ASCEND Wiki · Semaglutide profile · Retatrutide profile · All comparisons
Ready to calculate your exact draw volume?
Enter your vial size and BAC water to get precise IU markings for any dose.
Calculate Semaglutide dose → Calculate Retatrutide dose →